Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFORM-SVR: Interferon-Free HCV Treatment
NCT01278134Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2011
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of mericitabine, danoprevir in hepatitis C (HCV), sponsored by Roche. Started Feb 2011; status: completed.
02
Drugs
mericitabinedanoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01278134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278134.